Murine bladder tumors as models for human tumor immunity
Hellström, I.; Hellström, K.E.
National Cancer Institute Monograph 35: 125-127
1972
ISSN/ISBN: 0083-1921 PMID: 4659043 Document Number: 56711
Document emailed within 1 workday
Related Documents
Winkelhake, J.L.; Stampfl, S.; Zimmerman, R.J. 1987: Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models Cancer Research 47(15): 3948-3953Brennan, M.J. 1976: Murine and rat mammary tumors as models for the immunological study of human breast cancer Cancer Research 36(2 Part 2): 728-733
Gorczynski, R.M. 1974: Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals Journal of Immunology 112(5): 1826-1838
Murase, T.; Kobayashi, O.; Aota, Y.; Mitsuta, H.; Koshikawa, T. 1983: Histological study of urinary bladder tumor: DNA of rat urinary bladder tumor caused by N-butyl-N-(4-hydroxybutyl) nitrosamine and that of human bladder tumor Hinyokika Kiyo. Acta Urologica Japonica 29(3): 303-310
Gregersen, B.; Mommsen, S.; Svanholm, H. 1999: Bladder tumor antigen test versus urinary cytology in patients with bladder tumors Ugeskrift for Laeger 161(14): 2071-2073
Rahman, S.M.; Kawashima, K.; Nakashima, I.; Nagase, F. 1988: Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210 Cancer Research 48(22): 6450-6454
Legrue, S.J.; Ananthaswamy, H.N.; Simcik, W.J. 1989: Afferent and efferent specificity in the induction and elicitation of parental cross-protective immunity by an immunogenic murine tumor variant: associative recognition of a unique tumor-specific antigen on somatic cell hybrids Cancer Research 49(17): 4747-4751
Evans, G.F.; Snyder, Y.M.; Butler, L.D.; Zuckerman, S.H. 1989: Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models Circulatory Shock 29(4): 279-290
Mortensen, R.F. 1979: Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition Journal of the National Cancer Institute 62(1): 157-163
Páez Borda, A.; Angulo Frutos, J.; Luján Galán, M.; Llanes González, L.; Berenguer Sánchez, A. 1998: Kinetics of in vitro clonal growth of the murine MB-49 bladder tumor cell line Archivos Espanoles de Urologia 51(4): 319-324
Mirabelli, C.K.; Johnson, R.K.; Sung, C.M.; Faucette, L.; Muirhead, K.; Crooke, S.T. 1985: Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models Cancer Research 45(1): 32-39
Tahara, H.; Zeh, H.J.; Storkus, W.J.; Pappo, I.; Watkins, S.C.; Gubler, U.; Wolf, S.F.; Robbins, P.D.; Lotze, M.T. 1994: Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo Cancer Research 54(1): 182-189
Yin, D.; Zhang, X.; Feng, Y. 1996: Effects of recombinant human tumor necrosis factor on the development of ascitic tumor and expression of c-erbB2 in the nude mouse models of ovarian cancer Zhonghua Fu Chan Ke Za Zhi 31(5): 291-292
Lubet, R.A.; Carlson, D.E. 1978: Immunity against MOPC 104E plasmacytoma: effects of tumor size and time post therapy on in vivo tumor immunity Journal of the National Cancer Institute 60(5): 1107-1111
Littman, B.H.; Meltzer, M.S.; Cleveland, R.P.; Zbar, B.; Rapp, H.J. 1973: Tumor-specific, cell-mediated immunity in guinea pigs with tumors Journal of the National Cancer Institute 51(5): 1627-1635
Tomita, Y.; Himeno, K.; Nomoto, K.; Endo, H.; Hirohata, T. 1987: Augmentation of tumor immunity against syngeneic tumors in mice by beta-carotene Journal of the National Cancer Institute 78(4): 679-681
Maier, U.; Kuber, W. 1983: Drug prevention of recurrence in bladder tumors. Intravesical adriblastin instillation following transurethral resection of non-infiltrating bladder tumors Fortschritte der Medizin 101(12): 535-540
Jansa, P. 1982: Morphological correlates of anti-tumor immunity. I. Reactions to dinitrochlorobenzene and tissue of autologous tumors Ceskoslovenska Patologie 18(3): 183-187
Ferrantini, M.; Giovarelli, M.; Modesti, A.; Musiani, P.; Modica, A.; Venditti, M.; Peretti, E.; Lollini, P.L.; Nanni, P.; Forni, G. 1994: IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells Journal of Immunology 153(10): 4604-4615
Toyoshima, K.; Ito, N.; Hiasa, Y.; Kamamoto, Y.; Makiura, S. 1971: Tissue culture of urinary bladder tumor induced in a rat by N-butyl-N-(-4-hydroxybutyl)nitrosamine: establishment of cell line, Nara Bladder Tumor Ii Journal of the National Cancer Institute 47(5): 979-985